These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 9987890)

  • 1. A fatality due to the intranasal abuse of methylphenidate (Ritalin).
    Massello W; Carpenter DA
    J Forensic Sci; 1999 Jan; 44(1):220-1. PubMed ID: 9987890
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A case of suicide attempt with long-acting methylphenidate (Concerta).
    Ozdemir E; Karaman MG; Yurteri N; Erdogan A
    Atten Defic Hyperact Disord; 2010 Nov; 2(3):103-5. PubMed ID: 21432595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Megadose intranasal methylphenidate (ritalin) abuse in adult attention deficit hyperactivity disorder.
    Coetzee M; Kaminer Y; Morales A
    Subst Abus; 2002 Sep; 23(3):165-9. PubMed ID: 12444349
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Orofacial dyskinesia induced by nasal Ritalin(R) (methylphenidate) sniffing: a rare case report from Switzerland.
    Marti G; Fattinger K; Zimmermann H; Exadaktylos A
    Hum Exp Toxicol; 2013 Mar; 32(3):332-4. PubMed ID: 23174746
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intranasal abuse of prescribed methylphenidate.
    Garland EJ
    J Am Acad Child Adolesc Psychiatry; 1998 Dec; 37(12):1242-3. PubMed ID: 9847492
    [No Abstract]   [Full Text] [Related]  

  • 6. Intranasal abuse of prescribed methylphenidate.
    Garland EJ
    J Am Acad Child Adolesc Psychiatry; 1998 Jun; 37(6):573-4. PubMed ID: 9628076
    [No Abstract]   [Full Text] [Related]  

  • 7. [Central nervous system stimulants and their potential risk of abuse in hyperkinetic disorders].
    Aanonsen NO
    Tidsskr Nor Laegeforen; 1999 Nov; 119(27):4040-2. PubMed ID: 10613094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relative benefits of stimulant therapy with OROS methylphenidate versus mixed amphetamine salts extended release in improving the driving performance of adolescent drivers with attention-deficit/hyperactivity disorder.
    Cox DJ; Merkel RL; Moore M; Thorndike F; Muller C; Kovatchev B
    Pediatrics; 2006 Sep; 118(3):e704-10. PubMed ID: 16950962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcomes after accidental pediatric ingestions of (dextro)amphetamine and methylphenidate.
    LoVecchio F; Ozimek J; Sawyers B; Thole D
    Am J Emerg Med; 2009 Oct; 27(8):933-4. PubMed ID: 19857410
    [No Abstract]   [Full Text] [Related]  

  • 10. Need for bedtime dose of ritalin.
    Rogers WB
    Pediatrics; 1996 Aug; 98(2 Pt 1):314. PubMed ID: 8692642
    [No Abstract]   [Full Text] [Related]  

  • 11. Pleasure and discipline in the uses of Ritalin.
    Keane H
    Int J Drug Policy; 2008 Oct; 19(5):401-9. PubMed ID: 17884422
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Electrocardiographic effects of methylphenidate overdose.
    Hill SL; El-Khayat RH; Sandilands EA; Thomas SH
    Clin Toxicol (Phila); 2010 May; 48(4):342-6. PubMed ID: 20507245
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Continuity of methylphenidate treatment for attention-deficit/hyperactivity disorder.
    Marcus SC; Wan GJ; Kemner JE; Olfson M
    Arch Pediatr Adolesc Med; 2005 Jun; 159(6):572-8. PubMed ID: 15939858
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [General anesthesia for two patients taking methylphenidate (Ritalin)].
    Kasuga T; Meno A; Honda M; Momoeda K; Nagase M; Hanaoka K
    Masui; 2008 Jun; 57(6):748-51. PubMed ID: 18546908
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Severe toxicity due to injected but not oral or nasal abuse of methylphenidate tablets.
    Bruggisser M; Bodmer M; Liechti ME
    Swiss Med Wkly; 2011; 141():w13267. PubMed ID: 21984207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Is Ritalin prescribed insufficiently to hyperactive children in Nordland?].
    Neraal T
    Tidsskr Nor Laegeforen; 2001 May; 121(14):1735-6. PubMed ID: 11446022
    [No Abstract]   [Full Text] [Related]  

  • 17. Oral megadose methylphenidate ingestion for suicide attempt.
    Poulton A
    Pediatr Int; 2010 Oct; 52(5):852. PubMed ID: 20880313
    [No Abstract]   [Full Text] [Related]  

  • 18. Stimulant actions in rodents: implications for attention-deficit/hyperactivity disorder treatment and potential substance abuse.
    Kuczenski R; Segal DS
    Biol Psychiatry; 2005 Jun; 57(11):1391-6. PubMed ID: 15950013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methylphenidate misuse in adult patients and the impact of therapeutic use.
    Jensen LS; Pagsberg AK; Dalhoff K
    Hum Exp Toxicol; 2015 May; 34(5):460-7. PubMed ID: 25062974
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Attention deficit hyperactivity disorder: pharmacological options that are not "Ritalin"].
    Shmueli D; Gross-Tsur V
    Harefuah; 2005 Aug; 144(8):572-6, 597. PubMed ID: 16146157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.